申请人:OXIGENE, INC.
公开号:US20130296605A1
公开(公告)日:2013-11-07
This invention is directed to compound of Formula I and methods of using these compounds in the treatment of conditions in which modulation of a cathepsin, particularly cathepsin K or cathepsin L, will be therapeutically useful.
本发明涉及公式I的化合物及其在治疗调节蛋白酶的情况下,特别是治疗有益的蛋白酶K或蛋白酶L的方法。